Kenneth Locke and Ian Smith, industry leaders in Cell and Gene Therapy, join as iVexSol advisors
News
Viral vector manufacturing and transduction processes today are lengthy and inconsistent
Lexington, MA – (March 22, 2022) iVexSol, Inc., a lentiviral vector manufacturing company is pleased to announce the appointment of Sean Brown as Senior Vice President of Operations.
LEXINGTON, Mass., Jan. 4, 2022 /PRNewswire/ -- iVexSol, Inc., a lentiviral vector manufacturing company announces the appointment of Amitabha Deb, Ph.D. as Senior Vice President of Process Sciences and MS&T.
A gateway to explore a next generation stable lentiviral vector manufacturing technology
FOR IMMEDIATE RELEASE
Technology targets critical shortage of viral vectors for the rapidly
expanding field of cell and gene therapeutics
Our Science
Kenneth Locke and Ian Smith, industry leaders in Cell and Gene Therapy, join as iVexSol advisors
Viral vector manufacturing and transduction processes today are lengthy and inconsistent
Lexington, MA – (March 22, 2022) iVexSol, Inc., a lentiviral vector manufacturing company is pleased to announce the appointment of Sean Brown as Senior Vice President of Operations.
LEXINGTON, Mass., Jan. 4, 2022 /PRNewswire/ -- iVexSol, Inc., a lentiviral vector manufacturing company announces the appointment of Amitabha Deb, Ph.D. as Senior Vice President of Process Sciences and MS&T.
A gateway to explore a next generation stable lentiviral vector manufacturing technology
FOR IMMEDIATE RELEASE
Technology targets critical shortage of viral vectors for the rapidly
expanding field of cell and gene therapeutics